LIPIDS: 60 Second Insights
Published: 10 August 2018
-
Views:
975
-
Likes:
7
-
Views:
975
-
Likes:
7
-
Up Next
-
45sPart 4 | Session 1 Christopher Cannon
-
53sPart 4 | Session 2 Wolfgang Koenig
-
31sPart 5 | Session 1 Christopher Cannon
-
48sPart 5 | Session 2 Wolfgang Koenig
-
47sPart 6 | Session 1 Christopher Cannon
-
53sPart 6 | Session 2 Wolfgang Koenig
-
43sPart 7 | Session 1 Christopher Cannon
-
57sPart 7 | Session 2 Wolfgang Koenig
-
48sPart 8 | Session 1 Christopher Cannon
-
53sPart 8 | Session 2 Wolfgang Koenig
-
44sPart 1 | Session 1 Christopher Cannon Christopher P Cannon
-
50sPart 1 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
46sPart 2 | Session 1 Christopher Cannon Christopher P Cannon
-
34sPart 2 | Session 2 Wolfgang Koenig Wolfgang Koenig
-
38sPart 3 | Session 1 Christopher Cannon Christopher P Cannon
Overview
A short series of 60-second insight videos on the LIPIDS trial.
More from this programme
Part 1
Which emerging compounds show the most promise in reducing LDL?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 2
What is required for PCSK9s to get wider spread adoption?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 3
How important is inflammation in atherosclerosis?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 4
Are statins over (or under) prescribed?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 5
Is cholesterol being managed sub- optimally? If so, what needs to improve?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 6
How low should LDL go?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 7
Is HDL good cholesterol?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Part 8
What is the greatest unmet need in lipid management?
| 2 sessions | |
| Christopher Cannon | Watch now |
| Wolfgang Koenig | Watch now |
Faculty Biographies
Wolfgang Koenig
Professor of Medicine/Cardiology
Wolfgang Koenig is a Professor of Medicine/Cardiology. He is a board-certified internist and interventional cardiologist specialized in intensive care medicine and has extensive experience in the molecular epidemiology of cardiovascular diseases. A former Director of the WHO-MONICA Augsburg Myocardial Infarction Register, Professor Koenig has held multiple clinical positions at the University of Ulm Medical Center. In April 2015 he joined the Deutsches Herzzentrum München, Technische Universität München and became an established investigator of the Munich Heart Alliance within the German Centre for Cardiovascular Research (DZHK) and is the Head of the Cardiometabolic Unit.
Professor Koenig serves on the steering committee of multiple large, international randomised clinical trials testing innovative targets in cardiovascular medicine. His research investigates the molecular basis of atherothrombogenesis including the interrelationship between hemostasis, inflammation, and…